Recombinant Neisseria meningitides β1,4-galactosyltransferase, E. coli

Cat. No.: X23-03-YW078

Recombinant Neisseria meningitides β1,4-galactosyltransferase, E. coli

Synonym: LgtB

  • Enzyme Commission Number: 2.4.1.90
Product Size
1 U; 5 U; 25 U
Price
Datasheet
MSDS
Properties
Description
It is a recombinant Neisseria meningitides β1,4-galactosyltransferase produced in E. coli. This product can be used to study the mode of action of the enzyme and its potential inhibitors, and can also be used as a glycoengineering tool to modify glycoprotein&glycan in vitro.
Molecular Weight
34 kDa
Unit Definition
One unit will catalyze the formation of 1 μmol of Galβ1, 4GlcNAc from UDP-Gal and GlcNAc in one minute at 37°C.
Source
Neisseria meningitides
Form
Lyophilized powder
Applications
This product can be used to study the mode ofaction of the enzyme and its potential inhibitors and as a glycoengineering tool to modify glycoproteins&glycan in vitro.
Storage
Store at -20°C.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.